08.24.2021
Therapeutics
$2,000,000.00
24 months
Microbiome-based therapeutics for Crohn's disease
This project aims to induce a durable remission by using a high-complexity synthetic microbiome community as a microbiota transplant; and an engineered microbe that can reprogram the immune system to decrease inflammation.